Documentos de van der Schouw Y.T. | REDI

Regresar

Mostrando 4 resultados de: 4

Filtros aplicados

Área temáticas: "Enfermedades"

Subtipo de publicación

Publisher

Área temáticas

Ginecología, obstetricia, pediatría, geriatría(4)

Farmacología y terapéutica(1)

Problemas sociales y servicios a grupos(1)

Salud y seguridad personal(1)

Área de conocimiento

Ginecología(2)

Medicina interna(1)

Año de Publicación

Origen

Palabras Claves

Breast Cancer(2)

Aromatase inhibitors(1)

Bisphosphonates(1)

Calcineurin inhibitors(1)

Clobetasol propionate(1)

EMAS clinical guide: Low-dose vaginal estrogens for postmenopausal vaginal atrophy

Abstract: Vaginal atrophy is common in postmenopausal women. This clinical guide provides the evidence for the

Palabras claves:

Low-dose, Postmenopausal, Vaginal atrophy, Vaginal estrogens

Ceasu I., Depypere H., Erel T., Faustino R. Pérez-López, Lambrinoudaki I., Rees M., Schenck-Gustafsson K., Simoncini T., Trémollieres F.A., van der Schouw Y.T.

EMAS clinical guide: Vulvar lichen sclerosus in peri and postmenopausal women

Abstract: Introduction: Vulvar lichen sclerosus (LS) is a chronic inflammatory disease which affects genital l

Palabras claves:

Calcineurin inhibitors, Clobetasol propionate, Corticosteroids, dyspareunia, Lichen sclerosus, Pimecrolimus, pruritus, Tacrolimus, Testosterone, Vulvar kraurosis

Ceausu I., Depypere H., Faustino R. Pérez-López, Lambrinoudaki I., Rees M., Schenck-Gustafsson K., Simoncini T., Tamer Erel C., Trémollieres F.A., van der Schouw Y.T.

EMAS position statement: Individualized breast cancer screening versus population-based mammography screening programmes

Abstract: Introduction Breast cancer is the most prevalent cancer in women, with slightly more than ten percen

Palabras claves:

Breast Cancer, Individualized, Mammography screening

Ceausu I., Depypere H., Desreux J., Erel T., Faustino R. Pérez-López, Lambrinoudaki I., Rees M., Schenck-Gustafsson K., Simoncini T., Trémollieres F.A., van der Schouw Y.T.

Osteoporosis management in patients with breast cancer: EMAS position statement

Abstract: Aromatase inhibitors (AIs) are the first-line recommended standard of care for postmenopausal estrog

Palabras claves:

adjuvant therapy, Aromatase inhibitors, Bisphosphonates, Breast Cancer, Denosumab, fractures, OSTEOPOROSIS, screening

Ceausu I., Depypere H., Faustino R. Pérez-López, Lambrinoudaki I., Mueck A., Rees M., Senturk L.M., Simoncini T., Stevenson J.C., Stute P., Trémollieres F.A., van der Schouw Y.T.